What Waspito plans to do after winning LEAP's $250,000 grand prize
Category: HealthTech
Published: 2026-09-06T17:14:00.000Z
Waspito became the first African startup to win LEAP's Rocket Fuel grand prize. Here is what a $250,000 award and a new Saudi spotlight could mean for its next stage of growth.
From Rocket Fuel winner to what's next Winning is one thing; what a startup does with a win is another. Waspito, the Cameroon-founded telemedicine platform that became the first African company to take LEAP's $250,000 Rocket Fuel grand prize, now faces the question of how to turn a marquee Saudi moment into something durable. The win was reported by Business Tech Africa . TechScoop profiled the company's telemedicine-plus-mobile-lab model in a separate piece on how Waspito built its African footprint ; this piece looks forward. The Saudi opportunity on the table The most immediate strategic question is whether, and how, Waspito moves into the Saudi market. LEAP puts startups in the same venue as Saudi investors, corporates and healthcare operators, and a headline Rocket Fuel win is the kind of credential that opens doors that a cold outreach email would not. For a telemedicine and mobile-diagnostics business, Saudi Arabia represents both a large domestic healthcare market undergoing its own digitisation push and a potential base from which to service the wider Gulf. Entering Saudi Arabia would not be a simple copy-paste of Waspito's African playbook, however. Healthcare regulation, licensing for remote consultations and the logistics of running mobile diagnostic labs all differ market to market, and a Gulf entry typically requires local partners, whether on the clinical, insurance or logistics side. What the LEAP win buys Waspito is a faster route to those conversations rather than a shortcut around the underlying groundwork required to operate a regulated healthcare service in a new country. Expansion beyond home markets Even setting Saudi Arabia aside, Waspito's win adds momentum to its broader expansion ambitions across the African markets where it already operates and any new ones it chooses to enter next — a trajectory TechScoop places alongside the six other winners from LEAP's 2026 Rocket Fuel competition . A model built around remote consultations paired with mobile diagnostic labs is inherently repeatable market by market, provided the company can line up the local partnerships — clinics, lab-logistics providers, regulators — that any healthcare business needs before it can scale. Waspito's current operations are in Cameroon and Côte d'Ivoire, and after raising a $2.5 million seed extension in November 2023 it said it planned to expand into markets including Senegal and Gabon, according to Business Tech Africa . What the prize money and the platform can unlock The $250,000 prize itself is not scale-defining capital for a healthcare company operating across multiple markets, but it arrives alongside something more valuable: the LEAP platform's ability to put a winning startup in front of institutional decision-makers who might otherwise take months to reach through conventional fundraising channels. Combined with the $5.2 million in seed funding Waspito had raised before LEAP, the award functions less as a growth round and more as a credibility marker. That kind of marker tends to compound. A win at a globally watched event like LEAP gives a founder a concrete story to tell the next investor, the next government partner and the next potential acquirer, in Saudi Arabia or elsewhere, faster than the company could have manufactured that credibility on its own. Whether Waspito converts that into a formal Saudi launch, a new funding round, or simply a stronger position back home in its existing African markets, the Rocket Fuel win is now part of its pitch either way. The bigger picture for African healthtech There is also a wider signal in a Cameroon-founded company being singled out at a major Riyadh technology event. In the startup track at least, the top prize went to a company from outside the region. For African healthtech builders solving access problems rather than chasing hype cycles, Waspito's win is a useful reference point: proof that a model built around patient access rather than flashy technology can still win the argument on one of the industry's biggest regional stages. What happens over the next year will say more about the durability of that signal than the win itself does. If Waspito follows through with a Saudi or wider Gulf entry, it will become a template other African healthtech founders can point to when making their own case for regional expansion. If it does not, the win still stands as a marker of how far the company has come since it started connecting patients to doctors by video consultation in 2020. Sources Business Tech Africa